Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
West Coast Fermentation Center (WCFC) is an environmental biotechnology company that operated as a subsidiary of U.S. Microbics, Inc. Based in Carlsbad, California, the center specialized in the large-scale cultivation of specialized microbial cultures used for bioremediation, agriculture, and industrial waste treatment. The facility housed a microbe laboratory, a pilot plant, and a quality control center, utilizing fermentation technology and combinatorial liquefaction to produce proprietary microbial blends. These engineered microorganisms were designed to degrade toxic pollutants such as hydrocarbons, MTBE, and perchloroethylene in soil and groundwater. Historically, WCFC served as the primary manufacturing arm for its parent company's environmental product lines, including Bi-Agra and Remediline. In 2007, the center's assets and intellectual property were the subject of an acquisition agreement by Sub Surface Waste Management of Delaware to integrate microbial production with field remediation services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on West Coast Fermentation Center.